FDA Approves Gilead's HIV Med; Rival Claims Infringement

Hours after the U.S. Food and Drug Administration approved Gilead Sciences Inc.’s new HIV medication Biktarvy, rival ViiV Healthcare Co. filed a patent infringement lawsuit in Delaware federal court Wednesday accusing...

Already a subscriber? Click here to view full article